Diagnostic accuracy of GeneReady MTB assay on sputum for detecting pulmonary tuberculosis: a prospective multicenter study in China
Journal of Clinical Microbiology · 12.08.2026 · 64 (8)
DOI: 10.1128/jcm.01713-25 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 12.08.2026. Verfasst von Yuanyuan Shang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Instit…. Hauptthemen laut MEDLINE: Sputum, Tuberculosis, Pulmonary, Mycobacterium tuberculosis, Molecular Diagnostic Techniques. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Health Commission High-Level Public Health Talent Construction Project, Capital Health Development Research Program, Guangxi Science and Technology Major Program.
Abstract (Originalsprache)
In this prospective multicenter study, we aimed to evaluate the diagnostic accuracy of the novel GeneReady MTB assay on sputum for the detection of pulmonary tuberculosis (TB). Participants with symptoms suggestive of active pulmonary TB from three Chinese hospitals underwent testing with GeneReady, smear microscopy, mycobacterial culture, and Xpert MTB/RIF (G4) assay. GeneReady demonstrated an analytic limit of detection (LOD) of 23.34 CFU/mL (95% confidence interval [95% CI]: 16.96–43.05). A total of 537 participants meeting the inclusion criteria were included in our analysis. Against a microbiological reference standard, GeneReady had a sensitivity of 92.46% (319/345, 95% CI: 89.02%–94.92%) and a specificity of 96.35% (185/192, 95% CI: 92.33%–98.39%). When stratified by bacterial load, the sensitivity of GeneReady was higher in smear-positive (96.86%) versus smear-negative (87.01%) patients. When compared with Xpert MTB/RIF (G4), GeneReady showed a positive percent agreement of 94.55% (95% CI: 91.48%–96.73%) and a negative percent agreement of 93.24% (95% CI: 88.68%–96.11%). To conclude, GeneReady showed diagnostic accuracy comparable to Xpert MTB/RIF (G4). Its rapid turnaround, lower cost, and ease of use support its potential as an initial diagnostic tool for pulmonary TB in resource-limited settings. Further studies are warranted to evaluate its diagnostic accuracy in clinical settings across different patient populations. IMPORTANCE Tuberculosis (TB) remains a global health crisis, hindered by diagnostic gaps in resource-limited settings where high costs restrict access to accurate molecular testing. This study demonstrates that the novel GeneReady MTB assay provides diagnostic accuracy comparable to the widely used Xpert MTB/RIF (G4) assay, but at a significantly lower cost and with simplified operation. By offering a rapid, affordable, and accurate alternative, this test has the potential to expand access to quality TB diagnosis in primary and community healthcare settings, thereby improving case detection and supporting global TB control efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
- Katharine Hsu International Research Centre of Human Infectious Diseases, Shandong Public Health Clinical Centre Affiliated to Shandong University, Jinan, China.
- Department of Clinical Laboratory, The Fifth People's Hospital of Suzhou, The Affiliated Infectious Diseases Hospital, Suzhou Medical College of Soochow University, Suzhou, China.
- Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing Chest Hospital, Beijing, China.
ORCID-Profile: Shanshan Li, Liang Li, Yu Pang
Förderung
- Beijing Municipal Health Commission High-Level Public Health Talent Construction Project
- Capital Health Development Research Program
- Guangxi Science and Technology Major Program
- General Program of the National Natural Science Foundation of China
- Major Program of the National Natural Science Foundation of China
Zitieren
APA
Shang, Y., Tang, Z., Deng, Y., Xu, P., Ma, Z., Shi, J., Jing, W., Xue, J., Li, S., Li, L., & Pang, Y. (2026). Diagnostic accuracy of GeneReady MTB assay on sputum for detecting pulmonary tuberculosis: a prospective multicenter study in China. Journal of Clinical Microbiology, 64(8). https://doi.org/10.1128/jcm.01713-25
Vancouver
Shang Y, Tang Z, Deng Y, Xu P, Ma Z, Shi J, et al. Diagnostic accuracy of GeneReady MTB assay on sputum for detecting pulmonary tuberculosis: a prospective multicenter study in China. Journal of Clinical Microbiology. 2026;64(8). doi:10.1128/jcm.01713-25
BibTeX
@article{Shang2026,
author = {Shang, Yuanyuan and Tang, Zihan and Deng, Yunfeng and Xu, Ping and Ma, Zichun and Shi, Jin and Jing, Wei and Xue, Jing and Li, Shanshan and Li, Liang and Pang, Yu},
title = {Diagnostic accuracy of GeneReady MTB assay on sputum for detecting pulmonary tuberculosis: a prospective multicenter study in China},
journal = {Journal of Clinical Microbiology},
year = {2026},
volume = {64},
number = {8},
doi = {10.1128/jcm.01713-25}
}
EUVIMED